PureTech Health plc (PRTC.L)
GBp 164.0
(2.5%)
GBp 164.0
(2.5%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -95.48 Million USD | 36.49% |
| 2022 | -150.34 Million USD | -49.61% |
| 2021 | -100.49 Million USD | -1304.8% |
| 2020 | 8.34 Million USD | 110.81% |
| 2019 | -77.16 Million USD | -26.43% |
| 2018 | -61.03 Million USD | 13.29% |
| 2017 | -70.38 Million USD | -91.4% |
| 2016 | -36.77 Million USD | -410.91% |
| 2015 | 11.82 Million USD | 487.87% |
| 2014 | 2.01 Million USD | -71.33% |
| 2013 | 7.01 Million USD | -11.51% |
| 2012 | 7.93 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | -19.32 Million USD | 0.0% |
| 2024 Q1 | -19.32 Million USD | 9.95% |
| 2023 Q3 | -21.45 Million USD | 14.18% |
| 2023 Q4 | -21.45 Million USD | 0.0% |
| 2023 Q1 | -24.99 Million USD | 15.64% |
| 2023 Q2 | -24.99 Million USD | 0.0% |
| 2023 FY | -95.48 Million USD | 36.49% |
| 2022 Q1 | -38.77 Million USD | 51.85% |
| 2022 FY | -150.34 Million USD | -49.61% |
| 2022 Q4 | -29.63 Million USD | 0.0% |
| 2022 Q3 | -29.63 Million USD | 23.57% |
| 2022 Q2 | -38.77 Million USD | 0.0% |
| 2021 Q2 | -21.24 Million USD | 0.0% |
| 2021 FY | -100.49 Million USD | -1304.8% |
| 2021 Q4 | -80.53 Million USD | -337.92% |
| 2021 Q3 | -18.38 Million USD | 13.45% |
| 2021 Q1 | -21.24 Million USD | 63.11% |
| 2020 Q1 | -15.7 Million USD | 10.07% |
| 2020 FY | 8.34 Million USD | 110.81% |
| 2020 Q2 | -15.7 Million USD | 0.0% |
| 2020 Q3 | -19.34 Million USD | -23.18% |
| 2020 Q4 | -57.59 Million USD | -197.75% |
| 2019 Q1 | -20.56 Million USD | -44.93% |
| 2019 Q3 | -17.46 Million USD | 15.08% |
| 2019 Q4 | -17.46 Million USD | 0.0% |
| 2019 Q2 | -20.56 Million USD | 0.0% |
| 2019 FY | -77.16 Million USD | -26.43% |
| 2018 Q4 | -14.18 Million USD | 0.0% |
| 2018 FY | -61.03 Million USD | 13.29% |
| 2018 Q3 | -14.18 Million USD | -0.33% |
| 2018 Q2 | -14.14 Million USD | 0.0% |
| 2018 Q1 | -14.14 Million USD | 17.37% |
| 2017 Q3 | -17.11 Million USD | 0.13% |
| 2017 FY | -70.38 Million USD | -91.4% |
| 2017 Q2 | -17.13 Million USD | 0.0% |
| 2017 Q1 | -17.13 Million USD | 7.42% |
| 2017 Q4 | -17.11 Million USD | 0.0% |
| 2016 Q4 | -18.5 Million USD | 0.0% |
| 2016 FY | -36.77 Million USD | -410.91% |
| 2016 Q2 | 121.5 Thousand USD | 0.0% |
| 2016 Q1 | 121.5 Thousand USD | -71.04% |
| 2016 Q3 | -18.5 Million USD | -15333.33% |
| 2015 Q3 | 419.5 Thousand USD | -92.37% |
| 2015 Q2 | 5.49 Million USD | 0.0% |
| 2015 Q1 | 5.49 Million USD | 915.62% |
| 2015 FY | 11.82 Million USD | 487.87% |
| 2015 Q4 | 419.5 Thousand USD | 0.0% |
| 2014 Q2 | 570 Thousand USD | 0.0% |
| 2014 Q1 | 570 Thousand USD | 2.61% |
| 2014 FY | 2.01 Million USD | -71.33% |
| 2014 Q4 | 541 Thousand USD | 0.0% |
| 2014 Q3 | 541 Thousand USD | -5.09% |
| 2013 FY | 7.01 Million USD | -11.51% |
| 2013 Q1 | 2.12 Million USD | 0.0% |
| 2013 Q3 | 2.12 Million USD | 0.0% |
| 2013 Q2 | 2.12 Million USD | 0.0% |
| 2013 Q4 | 555.5 Thousand USD | -73.87% |
| 2012 Q3 | 2 Million USD | 0.0% |
| 2012 Q2 | 2 Million USD | 0.0% |
| 2012 Q1 | 2 Million USD | 0.0% |
| 2012 FY | 7.93 Million USD | 0.0% |
| 2012 Q4 | 2.12 Million USD | 6.05% |
| 2011 Q4 | 2 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|